12-18
SHANGHAI,Dec. 16,2024--The Cambridge Generative AI in Education Conference 2024 recently concluded in Cambridge,UK. The event was co-organized by the Faculty of Education at the University of Cambridg12-18
The Brand\'s Fifth Asia Pacific Property will be an Urban Sanctuary in the Heart of the City BANGKOK,Dec. 16,2024--The Standard,Singaporehas officially opened its doors on December 15,2024. The proper12-18
SAN FRANCISCO andSUZHOU,China,Dec. 16,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua12-18
About us: Aurora Mobile (NASDAQ: JG) established in 2011,is a leading customer engagement and marketing technology service provider in China. Its business includes notification services,marketing grow12-18
MOUNTAIN VIEW,Calif.,Dec. 17,2024-- aiMotive,a leading provider of cutting-edge simulation and AI technologies,has joined forces with Safran Electronics & Defense to advance the testing and valid12-18
NEW YORK,Dec. 17,2024-- Multiplier,a leading global employment platform,announced today the appointments of Pratik Gandhi as Managing Director and Chief Operating Officer (MD & COO) and Matt Carr12-18
SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele12-18
SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm12-18
Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-00112-18
ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis